Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of XL147 (SAR245408) in Subjects With Advanced or Recurrent Endometrial Carcinoma

NCT01013324 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01013324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01013324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of XL147 (SAR245408) in Subjects With Advanced or Recurrent Endometrial Carcinoma
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2010
Completion date
March 31, 2013
Enrollment
67 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer, endometrial neoplasms